MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202511000621 A) filed by Zoencure Therapeutics Private Limited on January 03, 2025, for Humanized Anti-Cd19 Chimeric Antigen Receptor (car) For Treatment Of Diseases Associated With Cd19 Expression, Composition And Preparation Thereof.
Inventors include Deepak Rohila; and Rahul Katara.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: ABSTRACT The present invention relates to humanized anti-CD19 chimeric antigen receptor (CAR) polypeptide for the treatment of diseases associated with CD19 expression, such as B-cell malignancies. The present invention further relates to its nucleic acid encoding the CAR, vectors containing the polynucleotide encoding the CAR, immune cells expressing the CAR at their surface and composition comprising the CAR.
Disclaimer: Curated by HT Syndication.
